Avanos Medical, Inc.
AVNS
$13.30
-$0.7301-5.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 179.60M | 170.40M | 171.70M | 166.10M | 173.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 179.60M | 170.40M | 171.70M | 166.10M | 173.30M |
| Cost of Revenue | 81.60M | 77.50M | 76.10M | 71.30M | 78.30M |
| Gross Profit | 98.00M | 92.90M | 95.60M | 94.80M | 95.00M |
| SG&A Expenses | 96.00M | 69.80M | 75.50M | 80.10M | 84.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.30M | -600.00K | 2.10M | 200.00K | 1.00M |
| Total Operating Expenses | 170.80M | 153.90M | 160.00M | 158.60M | 156.30M |
| Operating Income | 8.80M | 16.50M | 11.70M | 7.50M | 17.00M |
| Income Before Tax | -420.50M | 9.50M | 6.20M | 1.50M | 8.90M |
| Income Tax Expenses | -23.50M | 3.60M | 1.90M | 1.00M | -2.10M |
| Earnings from Continuing Operations | -397.00M | 5.90M | 4.30M | 500.00K | 11.00M |
| Earnings from Discontinued Operations | -300.00K | -1.60M | -2.50M | -1.40M | -500.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -397.30M | 4.30M | 1.80M | -900.00K | 10.50M |
| EBIT | 8.80M | 16.50M | 11.70M | 7.50M | 17.00M |
| EBITDA | 19.90M | 28.20M | 23.00M | 18.90M | 28.50M |
| EPS Basic | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 |
| Normalized Basic EPS | 0.09 | 0.19 | 0.16 | 0.07 | 0.20 |
| EPS Diluted | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 |
| Normalized Diluted EPS | 0.09 | 0.19 | 0.16 | 0.07 | 0.20 |
| Average Basic Shares Outstanding | 46.00M | 46.00M | 45.90M | 46.20M | 46.20M |
| Average Diluted Shares Outstanding | 46.00M | 46.60M | 46.30M | 46.70M | 46.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
